All News #Library
Rare Diseases
Priovant`s Brepocitinib Nda For Dermatomyositis Accepted By FDA
03 Mar 2026 //
GLOBENEWSWIRE
Roivant and Priovant`s drug show Promising Result in Rare Disease
17 Sep 2025 //
PRESS RELEASE

Market Place
Sourcing Support